search
Company Information
USD
0.304
- (4.8%)
NASDAQ:PRPH, PROPHASE LABS, INC.
Industry: Diagnostics & Research
End of Day: 8 May 2025 GMT-4
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Address

711 Stewart Avenue
Suite 200

Classification

Sector

Healthcare

Industry Group

Medical Diagnostics & Research

Industry

Diagnostics & Research

Key Executives

Mr. Jed A. Latkin
COO
Mr. Robert A. Morse, Jr
Controller
Dr. Louis Gleckel,M.D.
Director
Mr. Ted Karkus
CEO/Chairman of the Board/Director
Mr. Jason Barr
Director
Mr. Warren Hirsch
Director

Ownership

Institution Holdings

Vanguard Group Inc
609,347 (3.377%)
Vanguard Investments Australia Ltd
415,568 (2.303%)
Renaissance Technologies Corp
245,710 (1.362%)
HighTower Advisors, LLC
173,124 (0.959%)
Geode Capital Management, LLC
137,409 (0.761%)
Fidelity Management & Research Company LLC
127,743 (0.708%)
Perritt Capital Management Inc.
85,900 (0.476%)
Goldman Sachs Group Inc
74,994 (0.416%)
BlackRock Inc
60,754 (0.337%)
Swisspartners (Liechtenstein) AG
50,000 (0.277%)

Individual Holdings

Mr. Ted Karkus
3,433,750 (20.377%)
Dr. Louis Gleckel,M.D.
273,840 (2.360%)
Mr. Jason Barr
30,962 (0.200%)

Funds Holdings

Vanguard US Total Market Shares ETF
415,568 (2.303%)
Vanguard Total Stock Market Index Fund
415,568 (2.303%)
KO Microcap Strategy
24,643 (0.137%)
BlackRock Extended Equity Market
23,351 (0.129%)
Fidelity Series Total Market Index Fund
17,884 (0.099%)
NT Ext Equity Mkt Idx Fd - DC - NL
8,973 (0.050%)
EA Bridgeway Omni Small-Cap Value ETF
3,436 (0.019%)
Extended Equity Market Fund M
2,887 (0.016%)
BNYM Mellon SL Market Completion Fund
985 (0.005%)
NT Ext Equity Mkt Indx Fd DC Lending
361 (0.002%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices